iRhythm Expands MCT Footprint with VitalConnect Acquisition

iRhythm is acquiring wearable biosensor company VitalConnect for $287.5M to expand its cardiac monitoring platform beyond 14-day patches into mobile cardiac telemetry (MCT) and hospital-to-home care. The acquisition broadens iRhythm's capabilities across multiple cardiac modalities and physiological parameters, targeting faster growth in the growing remote patient monitoring (RPM) market.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.